Search research articles
Contact Us
Filters
Showing results (71-80 of 186) with videos related to
Page
of 19
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 23, 2021
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1
Jeffrey Skolnik, David Hall, Donald A Barkauskas, et al.
Pediatric Blood & Cancer
|
January 13, 2021
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN)
Andrew Bukowinski, Bill Chang, Joel M Reid, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 19, 2014
Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants
Adam S Himebauch, Susan C Nicolson, Martha Sisko, et al.
Cancer Medicine
|
November 2, 2024
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514
Stuart L Cramer, Alyssa Terry Reddy, Charles Gene Minard, et al.
Pediatric Blood & Cancer
|
September 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712
Katherine Tarlock, Xiaowei Liu, Charles G Minard, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2011
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates
Leigh Marcus, Robert Murphy, Elizabeth Fox, et al.
The Oncologist
|
February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003
Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
International Journal of Pediatric Endocrinology
|
May 15, 2015
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
Maya Lodish, Alexandra Gkourogianni, Ethan Bornstein, et al.
Peptides
|
March 18, 2008
Regulation of ghrelin structure and membrane binding by phosphorylation
Eva Dehlin, Jianhua Liu, Samuel H Yun, et al.
Pediatric Blood & Cancer
|
November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study
Rochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 186) with videos related to
Sort By:
Page
of 19
Cancer Chemotherapy and Pharmacology
|
May 23, 2021
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1
Jeffrey Skolnik, David Hall, Donald A Barkauskas, et al.
Pediatric Blood & Cancer
|
January 13, 2021
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN)
Andrew Bukowinski, Bill Chang, Joel M Reid, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 19, 2014
Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants
Adam S Himebauch, Susan C Nicolson, Martha Sisko, et al.
Cancer Medicine
|
November 2, 2024
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514
Stuart L Cramer, Alyssa Terry Reddy, Charles Gene Minard, et al.
Pediatric Blood & Cancer
|
September 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712
Katherine Tarlock, Xiaowei Liu, Charles G Minard, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2011
The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates
Leigh Marcus, Robert Murphy, Elizabeth Fox, et al.
The Oncologist
|
February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003
Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
International Journal of Pediatric Endocrinology
|
May 15, 2015
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
Maya Lodish, Alexandra Gkourogianni, Ethan Bornstein, et al.
Peptides
|
March 18, 2008
Regulation of ghrelin structure and membrane binding by phosphorylation
Eva Dehlin, Jianhua Liu, Samuel H Yun, et al.
Pediatric Blood & Cancer
|
November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study
Rochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Page
of 19